Gilead Sciences (GILD)

Cash & Equivalents

$3.18B

Quarterly · Period ending: · USD

GILD logo

GILD Cash & Equivalents

Latest reported$3.18B
GILD Quarterly Cash & Equivalents ($10.30M → $3.18B)
High-resolution chart · PNG

GILD cash & equivalents history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Gilead Sciences Cash & Equivalents — Quarterly (USD)
Period endingCash & Equivalents (USD)
3,179,000,000
7,628,000,000
7,564,000,000
7,330,000,000
5,144,000,000
7,926,000,000
9,991,000,000
5,037,000,000
2,772,000,000
4,718,000,000
6,085,000,000
5,705,000,000
5,704,000,000
4,936,000,000
5,412,000,000
4,699,000,000
4,739,000,000
4,296,000,000
5,338,000,000
4,362,000,000
4,893,000,000
4,065,000,000
5,997,000,000
12,886,000,000
6,746,000,000
10,051,000,000
11,631,000,000
9,474,000,000
11,240,000,000
16,927,000,000
17,940,000,000
14,569,000,000
13,234,000,000
7,643,000,000
7,588,000,000
11,508,000,000
8,712,000,000
10,285,000,000
8,229,000,000
9,809,000,000
6,485,000,000
6,315,000,000
12,851,000,000
13,965,000,000
7,417,000,000
10,635,000,000
10,027,000,000
6,209,060,000
8,730,522,000
6,404,153,000
2,113,000,000
2,010,736,000
2,202,176,000
1,863,972,000
1,803,694,000
1,550,710,000
1,625,500,000
1,451,942,000
9,883,777,000
909,359,000
905,779,000
1,835,978,000
907,879,000
1,022,993,000
1,482,639,000
936,880,000
1,272,958,000
1,024,599,000
1,040,874,000
1,663,646,000
1,459,302,000
1,209,424,000
1,119,599,000
722,884,000
968,086,000
584,128,000
701,648,000
729,142,000
816,007,000
559,580,000
884,449,000
268,677,000
707,913,000
592,722,000
793,618,000
281,941,000
280,909,000
301,450,000
226,563,000
155,585,000
194,719,000
103,317,000
169,355,000
117,477,000
616,931,000
121,608,000
122,006,000
115,086,000
123,490,000
37,346,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.